[Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo].
D000818:Animals; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D001780:Blood Coagulation Tests; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D010958:Plasminogen / Q000494:pharmacology; D011480:Protease Inhibitors; D011817:Rabbits; D013300:Streptokinase / Q000494:pharmacology; D013916:Thrombelastography
D000933:Antifibrinolytic Agents; D011480:Protease Inhibitors; D010958:Plasminogen; D013300:Streptokinase
Zum Nachweis der antifibrinolytischen Wirkung des Proteaseninhibitors Contrykal in vivo.